𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Use of Low-Dose Methotrexate in Children with Chronic Anterior and Intermediate Uveitis

✍ Scribed by A.R. Malik; C. Pavesio

Book ID
116589717
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
39 KB
Volume
10
Category
Article
ISSN
1528-3933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized trial of parenteral methotr
A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
✍ Nicolino Ruperto; Kevin J. Murray; Valeria Gerloni; Nico Wulffraat; Sheila Knupp πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 2 views

## Abstract ## Objective To compare the safety and efficacy of parenteral methotrexate (MTX) at an intermediate dosage (15 mg/m^2^/week) versus a higher dosage (30 mg/m^2^/week) in patients with polyarticular‐course juvenile idiopathic arthritis (JIA) who failed to improve while receiving standard

Randomized comparison of moderate-dose m
Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: A Childrens Cancer Group study
✍ Lange, Beverly J.; Blatt, Julie; Sather, Harland N.; Meadows, Anna T. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 559 KB

Methotrexate (MTX) infusions of 500-1,000 mg/m2 over 24 hours may improve survival and prevent relapse in children with acute lymphoblastic leukemia (ALL). Childrens Cancer Group (CCG) Study 139 compared weekly oral methotrexate 20 mg/m2/ week (oral MTX) to MTX 500 mg/m2 infused over 24 hours (IV MT